共 50 条
Evaluation of T-Type Calcium Channel Blockers against Human Pancreatic MIA PaCa-2 Carcinoma Xenografts
被引:6
|作者:
Park, Jin Yeong
[1
,2
]
Choi, Heung Woo
[1
,2
]
Choi, Doo Li
[1
,2
]
Jang, Sun Jeong
[1
,2
]
Kim, Je Hak
[3
]
Lee, Joo Han
[2
,3
]
Choo, Doug Joon
[1
,2
]
Kim, Jungahn
[1
]
Lee, Kyung-Tae
[4
]
Lee, Jae Yeol
[1
,2
]
机构:
[1] Kyung Hee Univ, Coll Sci, Res Inst Basic Sci, Seoul 130701, South Korea
[2] Kyung Hee Univ, Coll Sci, Dept Chem, Seoul 130701, South Korea
[3] Boryung Pharm Co Ltd, Cent Res Inst, Kyonggi Do 425839, South Korea
[4] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Biochem, Seoul 130701, South Korea
基金:
新加坡国家研究基金会;
关键词:
T-type calcium channel;
3,4-Dihydroquinazoline;
Repeat dose toxicity;
MIA PaCa-2 xenografts;
CANCER-CELLS;
IN-VIVO;
TUMOR;
GROWTH;
DIFFERENTIATION;
PROLIFERATION;
MICE;
D O I:
10.5012/bkcs.2013.34.2.482
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
Two piperazine-containing 3,4-dihyroquinazolines (BK10007S/8S) have been synthesized, based on our previous work on the synthesis and antitumoral activity of 3,4-dihyroquinazolines. After evaluating them for T-type calcium channel blocking effect and in vitro anti-cancer effect, they were profiled for acute and repeat dose toxicity (40 mg/kg, 2 weeks) to BALB/c mice. BK10007S/8S were further in vivo evaluated against human pancreatic MIA PaCa-2 carcinoma in BALB/c(nu/nu) nude mice, which exhibited 54 and 61% tumor growth inhibition through 57-day oral administration of 2 mg/kg of body weight, respectively.
引用
收藏
页码:482 / 488
页数:7
相关论文